Using double-negative controls to adjust for healthy-user bias in a recombinant zoster vaccine safety study
American Journal of Epidemiology · 2025
DOI: 10.1093/aje/kwae439 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Epidemiology, 2025. Verfasst von Kendrick Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN 38105, United States. Hauptthemen laut MEDLINE: Herpes Zoster Vaccine, Herpes Zoster, Pharmacoepidemiology. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS, NIGMS NIH HHS, National Institutes of Health, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Unmeasured confounding is a major concern in many epidemiologic studies that are not randomized. Negative control methods can detect and reduce confounding by leveraging the proxies of the unmeasured confounders, including negative control outcomes (NCOs) and exposures (NCEs). An NCO is presumably unaffected by the exposure of interest but would be associated with unmeasured confounders; an NCE presumably does not affect the outcome of interest but would be associated with unmeasured confounders. A recently proposed double-negative control method leverages both NCOs and NCEs for unmeasured confounding bias. To demonstrate this relatively new methodology in pharmacoepidemiologic studies, we reanalyzed data from a prior safety study of recombinant zoster vaccine (RZV). The prior study compared risk of safety outcomes of individuals who received the RZV with those of unvaccinated comparators, using logistic regression with propensity score adjustment. We identified NCOs and NCEs that could be used to adjust for unmeasured confounding bias that could arise if RZV recipients are incomparable to the comparators due to unmeasured factors. The double-negative control analysis yielded relative risk estimates slightly closer to 1.0 than those reported previously, providing additional evidence of RZV safety that is less vulnerable to unmeasured confounding.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN 38105, United States.
- Seattle Children's Research Institute, Seattle, WA 98101, United States.
- Kaiser Permanente Washington Health Research Institute, Seattle, WA 98101, United States.
- Department of Biostatistics, University of Washington, Seattle, WA 98195, United States.
- Division of Research, Kaiser Permanente Northern California, Oakland, CA 94612, United States.
- Marshfield Clinic Research Institute, Marshfield, WI 54449, United States.
ORCID-Profile: Kendrick Li, Bruce H Fireman, Maria Sundaram, Hung-Fu X Tseng, Eric S Weintraub, Onchee Yu, Jennifer L Nelson, Xu Shi
Förderung
- Intramural CDC HHS
- NIGMS NIH HHS
- National Institutes of Health, National Institute of General Medical Sciences
- Centers for Disease Control and Prevention (CDC)
Zitieren
APA
Li, K., Emerman, I., Cook, A. J., Fireman, B. H., Sundaram, M., Tseng, H. X., Weintraub, E. S., Yu, O., Nelson, J. L., & Shi, X. (2025). Using double-negative controls to adjust for healthy-user bias in a recombinant zoster vaccine safety study. American Journal of Epidemiology. https://doi.org/10.1093/aje/kwae439
Vancouver
Li K, Emerman I, Cook AJ, Fireman BH, Sundaram M, Tseng HX, et al. Using double-negative controls to adjust for healthy-user bias in a recombinant zoster vaccine safety study. American Journal of Epidemiology. 2025. doi:10.1093/aje/kwae439
BibTeX
@article{Li2025,
author = {Li, Kendrick and Emerman, Iris and Cook, Andrea J and Fireman, Bruce H and Sundaram, Maria and Tseng, Hung-Fu X and Weintraub, Eric S and Yu, Onchee and Nelson, Jennifer L and Shi, Xu},
title = {Using double-negative controls to adjust for healthy-user bias in a recombinant zoster vaccine safety study},
journal = {American Journal of Epidemiology},
year = {2025},
doi = {10.1093/aje/kwae439}
}
EUVIMED